First assistants (FAs) can play an important role in achieving optimal outcomes and higher surgical case volumes. Part 1 of this two-part series discussed types, education, and certification of FAs (OR Manager, May 2021, pp 1, 15-18). Part 2 answers questions related to risk management and oversight, and discusses possible…
Editor's Note Urban hospitals bounced back faster than rural hospitals from surgical caseload decreases caused by the COVID-19 pandemic, finds a new study released May 13 by Caresyntax, a Boston-based developer of surgical intelligence and automation technologies. The study, “The State of Surgery: An Analysis of Surgical Trends During the…
Editor's Note The Food and Drug Administration (FDA), on April 20, identified the recall of Medtronic’s Bio-Console 560 Extracorporeal Blood Pumping Console as Class I, the most serious. The Console is used during heart surgery to pump and return blood to a patient during cardiopulmonary bypass. The recall was initiated…
Editor's Note The Food and Drug Administration (FDA), on April 12, identified the recall of Medtronic’s Evera, Viva, Brava, Claria, Amplia, Compia, and Visia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) as Class I, the most serious. The recall was initiated because of an unexpected and rapid…
Editor's Note The Food & Drug Administration (FDA), on April 9, identified the recall of Medtronic’s Valiant Navion Thoracic Stent Graft System as Class I, the most serious. The recall was initiated because of the risk of stent fractures and endoleak concerns. The system is used to repair lesions of…
Editor's Note The Food and Drug Administration (FDA), on March 24, identified the recall by Medtronic of its Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface as Class I, the most serious. The recall was issued because of potentially elevated levels of harmful bacterial endotoxins. Use of a device…
Editor's Note The Food and Drug Administration (FDA) on March 1 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) Pump Implant Kits as Class I, the most serious. The kit is part of the HeartWare HVAD System, which is used to help the heart pump blood…
Editor's Note The COVID-19 pandemic has resulted in a substantial decline in cardiac surgery volume and an unexplained increase in deaths after coronary artery bypass grafting (CABG), finds this study presented January 30 at the Annual Meeting of the Society of Thoracic Surgeons (STS). Researchers from the University of California,…
Editor's Note In a Scientific Statement, the American Heart Association (AHA) says marijuana use has no cardiovascular benefits and that it has been linked to an increased risk of heart attacks, atrial fibrillation, and heart failure. Though a full understanding of how marijuana use affects the heart and blood vessels…
Editor's Note The American College of Surgeons (ACS) on August 4 announced that it is strongly opposed to the Centers for Medicare & Medicaid Services (CMS) Physician Fee Schedule proposed rule for CY 2021. In the fee schedule, which is set to take place January 1, 2021, Medicare payments will…